Rtw Investments, LP Exagen Inc. Transaction History
Rtw Investments, LP
- $6.13 Billion
- Q4 2024
A detailed history of Rtw Investments, LP transactions in Exagen Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 1,511,866 shares of XGN stock, worth $6.4 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
1,511,866
Previous 1,511,866
-0.0%
Holding current value
$6.4 Million
Previous $4.67 Million
32.69%
% of portfolio
0.1%
Previous 0.07%
Shares
15 transactions
Others Institutions Holding XGN
# of Institutions
43Shares Held
6.05MCall Options Held
1.1KPut Options Held
6.4K-
Toronto Dominion Bank Toronto, Ontario, A6891KShares$3.77 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY535KShares$2.26 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$2.08 Million0.0% of portfolio
-
Morgan Stanley New York, NY484KShares$2.05 Million0.0% of portfolio
-
Perkins Capital Management Inc424KShares$1.79 Million1.67% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $68.8M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...